Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges-Reference-Cited by-同舟云学术

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

Published:2011-02 Issue:2 Volume:34 Page:269-280
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Bomsel Morgane,Tudor Daniela,Drillet Anne-Sophie,Alfsen Annette,Ganor Yonatan,Roger Marie-Gaëlle,Mouz Nicolas,Amacker Mario,Chalifour Anick,Diomede Lorenzo,Devillier Gilles,Cong Zhe,Wei Qiang,Gao Hong,Qin Chuan,Yang Gui-Bo,Zurbriggen Rinaldo,Lopalco Lucia,Fleury Sylvain

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference56 articles.

1. HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide;Alfsen;J. Biol. Chem.,2002

2. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1;Alfsen;J. Immunol.,2001

3. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells;Amacker;Int. Immunol.,2005

4. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope;Barnett;AIDS,2008

5. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier;Bomsel;Nat. Med.,1997

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characteristics of rhesus macaque interferon-lambda receptor 1 (mmuIFNLR1): Sequence identity, distribution and alteration after simian-human immunodeficiency virus infection in the skin and buccal mucosa;Developmental & Comparative Immunology;2024-11

2. Saccharomyces cerevisiae cells that display norovirus P induce both systemic and mucosal neutralizing antibodies;Virology;2024-06

3. Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity;European Journal of Pharmaceutics and Biopharmaceutics;2023-10

4. The emergence of nanovaccines as a new paradigm in virological vaccinology: a review;Exploration of Immunology;2023-08-31

5. Nanocarrier vaccine therapeutics for global infectious and chronic diseases;Materials Today;2023-06